Lewy Body Dementia (LBD)Symptoms, Doctors, Treatments, Advances & More
Lewy Body Dementia (LBD) Overview
Learn About Lewy Body Dementia (LBD)
- Lewy body dementia
- Autosomal dominant diffuse Lewy body disease
- DLB
- Diffuse Lewy body disease
- Lewy body disease
Muhammad Ali Parkinson Center
My mission, along with the Dignity Health Medical Group, is to focus on innovative clinical care and the pursuit of excellence through scholarly activities. This allows me to provide patients with state-of-the-art patient services and exceptional patient experiences. Dr. Shill is rated as an Elite provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Essential Tremor, Movement Disorders, Deep Brain Stimulation, and Tissue Biopsy. Dr. Shill is board certified in Psychiatry & Neurology (Neurology). Dr. Shill is currently accepting new patients.
Banner Sun Health Research Institute
In my spare time... I enjoy hiking, swimming, and playing fetch with my Sheltie dog. Dr. Shprecher is rated as an Elite provider by MediFind in the treatment of Lewy Body Dementia (LBD). He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Movement Disorders, Parkinson's Disease, Lewy Body Dementia (LBD), and Progressive Supranuclear Palsy. Dr. Shprecher is board certified in American Board Of Psychiatry & Neurology. Dr. Shprecher is currently accepting new patients.
Johns Hopkins Outpatient Center
Dr. Scholz is a neurologist and geneticist specializing in neurodegenerative disorders such as Parkinson's disease, atypical parkinsonism and dementia syndromes. She received her medical degree from the Medical University Innsbruck, Austria. Following graduation, she was a postdoctoral fellow at the National Institutes of Health under the supervision of Drs. Andrew Singleton and John Hardy. She obtained a Ph.D. in neurogenomics from the University College London, UK in 2010. She then moved to Baltimore to complete her neurology residency training at Johns Hopkins. In 2015 Dr. Scholz received the McFarland Transition to Independence Award for Neurologist-Scientists. She is Lasker Clinical Research Scholar at the National Institute of Neurological Disorders and Stroke focusing on genetic causes of neurodegenerative syndromes, and an adjunct faculty member at Johns Hopkins' department of neurology. Dr. Scholz is rated as an Elite provider by MediFind in the treatment of Lewy Body Dementia (LBD). She is also highly rated in 17 other conditions, according to our data. Her clinical expertise encompasses Lewy Body Dementia (LBD), Multiple System Atrophy, Movement Disorders, and Parkinson's Disease.
Summary: BioFINDER-Sleep study was established in 2021 and will include patients with early Parkinson´s disease (PD) and persons with iRBD to provide essential insights into the underlying mechanisms of the progressive neurodegenerative processes in central and peripheral nervous systems. Briefly polysomnography will be used to establish the presence of RBD in both the early PD cohort and in the iRBD cohor...
Summary: The overall aim of the study is to improve the diagnostic accuracy of AD and cognitive impairment in primary care settings to ensure better care and treatment as well as facilitate correct referrals to specialized memory clinics. The investigators will strive to recruit diverse and representative populations of patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI) and m...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

